Trailing-twelve-month (TTM) revenue is $19.41 Million with a year-over-year growth of (3.72%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,823,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $4,886,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-10 |
| Q1 FY2026Period ended 2026-03-31 | $5,085,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $4,611,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $19,405,000 |
Current P/S: $19,965,344 market capitalization ÷ $19,405,000 TTM revenue = 1.03x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.61M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:57:30.319Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| BillingAndRelatedServicesMember | N/A | N/A | $14M | N/A | N/A | N/A |
| License | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | $10M | $9M | $8M | $9M | $7M |
| Europe | N/A | $12M | $11M | $12M |
$19.41M
$19.41 Million
(3.72%)
vs. $20.15M a year ago (TTM)
(5.01%)
5 Year compound annual growth rate
1 Year
(3.72%)
3 Year
(3.15%)
5 Year
(5.01%)
10 Year
+0.25%
15 Year
+0.12%
20 Year
+0.00%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $19.46M | ($1.99M) | (9.27%) |
| 2024 | $21.45M | ($166,000) | (0.77%) |
| 2023 | $21.61M | +$61,000 | +0.28% |
| 2022 | $21.55M | ($4.78M) | (18.15%) |
| 2021 | $26.33M | +$2.96M | +12.65% |
| 2020 |
TTM Growth
(3.72%)
3-Year CAGR
(3.15%)
5-Year CAGR
(5.01%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:57:30.319Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $558,000 |
| $728,000 |
| $733,000 |
| MessagingMember | N/A | N/A | $12M | N/A | N/A | N/A |
|---|
| Product Line | $14M | N/A | N/A | N/A | N/A | N/A |
|---|
| Product line "C" | $6M | N/A | N/A | N/A | N/A | N/A |
|---|
| Product Line B | $3M | N/A | N/A | N/A | N/A | N/A |
|---|
| ProductLineBMember | N/A | $3M | N/A | N/A | N/A | N/A |
|---|
| ProductLineCMember | N/A | $9M | N/A | N/A | N/A | N/A |
|---|
| ProductLineMember | N/A | $12M | N/A | N/A | N/A | N/A |
|---|
| Service | N/A | N/A | N/A | $21M | $21M | $19M |
|---|
| $11M |
| $11M |
| InIsraelMember | N/A | $893,000 | N/A | N/A | N/A | N/A |
|---|
| ISRAEL | $1M | N/A | N/A | N/A | N/A | N/A |
|---|
| Other Countries Member | N/A | N/A | $808,000 | $1M | $475,000 | $397,000 |
|---|
| OtherCountriesMember | N/A | $392,000 | N/A | N/A | N/A | N/A |
|---|
| $23.37M |
| +$710,000 |
| +3.13% |
| 2019 | $22.66M | +$4.53M | +24.97% |
| 2018 | $18.14M | +$73,000 | +0.40% |
| 2017 | $18.06M | +$10,000 | +0.06% |
| 2016 | $18.05M | ($2.88M) | (13.74%) |
